These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9347672)

  • 1. Amineptine in the treatment of amphetamine withdrawal: a placebo-controlled, randomised, double-blind study.
    Jittiwutikan J; Srisurapanont M; Jarusuraisin N
    J Med Assoc Thai; 1997 Sep; 80(9):587-92. PubMed ID: 9347672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment.
    Srisurapanont M; Jarusuraisin N; Jittiwutikan J
    Aust N Z J Psychiatry; 1999 Feb; 33(1):94-8. PubMed ID: 10197891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for amphetamine withdrawal.
    Shoptaw SJ; Kao U; Heinzerling K; Ling W
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003021. PubMed ID: 19370579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy with reboxetine in amphetamine withdrawal syndrome.
    Molina JD; de Pablo S; López-Muñoz F; Alamo C; Blasco-Fontecilla H; González-Parra S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1353-5. PubMed ID: 16631296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion for amphetamine withdrawal syndrome.
    Chan-Ob T; Kuntawongse N; Boonyanaruthee V
    J Med Assoc Thai; 2001 Dec; 84(12):1763-5. PubMed ID: 11999825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic action lag time and resistance to treatment].
    Peretti CS
    Encephale; 1999 Jun; 25 Spec No 2():49-54. PubMed ID: 10434159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
    Le Bon O; Murphy JR; Staner L; Hoffmann G; Kormoss N; Kentos M; Dupont P; Lion K; Pelc I; Verbanck P
    J Clin Psychopharmacol; 2003 Aug; 23(4):377-83. PubMed ID: 12920414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amineptine and amotival syndrome (author's transl)].
    Deniker P; Lôo H; Zarifian E; Peron P; Benyacoub A; Roux JM; Kamoun A
    Encephale; 1981; 7(1):59-64. PubMed ID: 7227285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsy Behav; 2007 May; 10(3):449-55. PubMed ID: 17350342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of thymo-analeptics and acceptability of amineptin compared to those of imipramine].
    Ropert R; Barte HN; Ostaptzeff G; Kamoun A
    Encephale; 1982; 8(3):389-403. PubMed ID: 7186460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bupropion. An antidepressant used to help smoking cessation].
    Taeron C
    Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antidepressant action of amineptine: controlled double blind test (author's transl)].
    Porot M; Gerstner C; François MA
    Therapie; 1979; 34(6):733-42. PubMed ID: 547447
    [No Abstract]   [Full Text] [Related]  

  • 20. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.